CMAX
Adelaide, South Australia, Australia
Research institute in Adelaide city centre, South Australia
5/21 North Terrace, Adelaide SA 5000
About CMAX
"Established in 1993 CMAX is one of Australia’s largest and most experienced clinical trial centres. Our expert team is committed to supporting innovative medical research in partnership with our national and international sponsors"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Concert Pharmaceuticals
5
Pfizer
4
Seqirus
4
Novavax
3
Qpex Biopharma, Inc.
3
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
3
Avanir Pharmaceuticals
2
Chengdu SciMount Pharmatech Co., Ltd.
2
Gmax Biopharm Australia Pty Ltd.
2
Hoffmann-La Roche
2
Lyndra Inc.
2
Clinical Trials at CMAX
During the past decade, CMAX conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 8 clinical trials were completed, i.e. on
average, 9.9% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 7 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of a Pandemic Influenza Vaccine in Elderly Participants
2006-10-01
2007-06-01
Completed
200
A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults
2008-03-01
2010-01-01
Completed
7,500
Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
2009-11-05
2010-05-13
Completed
64
Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
2010-06-01
2011-01-01
Completed
57
A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™
2010-02-01
2010-08-01
Completed
80
Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers
2010-03-01
2010-06-01
Completed
37
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CMAX" #1 sponsor was "Concert Pharmaceuticals" with 5 trials, followed by "Pfizer" with 4 trials
sponsored, "Seqirus" with 4 trials sponsored, "Novavax" with 3 trials sponsored and "Qpex Biopharma, Inc."
with 3 trials sponsored. Other sponsors include 81 different institutions and
companies that sponsored additional 78 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CMAX"
#1 collaborator was "CPR Pharma Services Pty Ltd, Australia" with 4 trials as a collaborator, "Novotech (Australia) Pty Limited" with 4 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Avance Clinical Pty Ltd." with 2 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at CMAX
According to Clinical.Site data, the most researched conditions in "CMAX" are
"Healthy" (20 trials), "Healthy Volunteers" (13 trials), "Influenza" (8 trials), "Bacterial Infections" (7 trials) and "Osteoarthritis" (3 trials). Many other conditions were trialed in "CMAX" in a lesser frequency.
Clinical Trials Intervention Types at CMAX
Most popular intervention types in "CMAX" are "Drug" (87 trials), "Biological" (19 trials), "Other" (10 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "RPX7009" (3 trials), "AVP-923" (2 trials), "CTP-730" (2 trials) and "Eurartesim" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CMAX
The vast majority of trials in "CMAX" are
97 trials for "All" genders and 8 trials for "Male" genders.
Clinical Trials Status at CMAX
Currently, there are NaN active trials in "CMAX".
undefined are not yet recruiting,
11 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 80 completed trials in CMAX,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in CMAX, 84 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".